News

HuATN-658 is designed to target the cell surface protein uPAR, which is found in high levels in some of the most deadly cancers. As part of the deal,

The launch of this product follows receipt of the final approval from the US Food and Drug Administration (FDA) for an abbreviated new drug application (ANDA). IGI Laboratories

For Trulicity, Eli Lilly Japan has secured a manufacturing/marketing license as a drug indicated to treat people with type 2 diabetes in Japan. Trulicity is a once-weekly glucagon-like

The BLA for daratumumab is to treat MM patients who have received at least three prior lines of therapy including both a proteasome inhibitor (PI) and an immunomodulatory

Bexarotene 75mg capsules are a generic version of Valeant’s Targretin Capsules. Mylan CEO Heather Bresch said: "Mylan’s launch of the first and only generic Targretin is another example

Entocort (budesonide) is currently approved in more than 40 countries to treat Crohn’s disease (CD) and ulcerative colitis (UC). The US rights of Entocort will remain with AstraZeneca,

As a result, Immune will transfer to Endo its previously licensed patents related to the use of topical lidocaine in acute and chronic back pain and Endo will

The amount of payment was not disclosed. The payment was triggered by the achievement of positive in vivo proof of concept data and progression of the Anticalin drug

Entresto (previously known as LCZ696) will be provided on prescription for patients whose condition is classified NYHA class II-IV and indicated to reduce the risk of cardiovascular death